Adipose tissue banking is a service that a growing number of physicians across plastic surgery, aesthetic medicine, orthopedics, and functional medicine are adding to their practices. Not as a departure from their clinical focus, but as a natural extension of it. The harvest technique is within existing physician skill sets, the regulatory framework is established and compliant, and the patient population most interested in banking is the same health-forward, cash-pay demographic that high-quality medical practices already serve. This post covers the clinical case, the practice workflow, the regulatory compliance framework, and what joining the Save My Fat provider network involves.
TLDR: The Save My Fat provider program adds a Section 361 HCT/P-compliant banking service to your practice using a harvest technique within existing physician skill sets. The patient population is health-forward and cash-pay. The regulatory framework is FDA-compliant tissue preservation, without treatment claims and without IND requirements. The program requires provider training, protocol adherence, and specimen handling per the Save My Fat chain-of-custody standard. Review onboarding at the provider program overview.
Important Disclaimer: The Save My Fat provider program is a tissue preservation service operating under 21 CFR Part 1271. Partner providers perform the harvest procedure. They do not provide stem cell treatments or therapies. No ADSC-based therapy for any specific condition is available through the Save My Fat program as a medical treatment. All content is for educational purposes only and does not constitute medical, legal, or financial advice.
Your patients are already asking about stem cells. Some of them are researching banking. Some of them are at risk of being directed toward unregulated clinics that will charge them significant money for services without a compliant regulatory framework or documented cell quality. The Save My Fat provider program gives you the option to be the credible, compliant answer to that question, in your practice, with your patients, under a regulatory framework that protects both of you.
This post is written directly for physicians evaluating the program. It covers the five questions that matter most: what the program requires, what it offers your patients, the compliance framework, the workflow in practice, and how to join.
The Clinical Case: Why Banking Fits Your Practice
Your Patients Are Already in the Market
The banking patient profile is the same patient demographic that high-quality medical practices already attract. Health-forward adults aged thirty-five to sixty-five, invested in preventive and longevity health, comfortable with cash-pay services, and looking for physicians who are ahead of the curve rather than behind it. These patients do not need to be convinced that proactive health investment has value. They are already doing it with genetic testing, continuous glucose monitoring, advanced diagnostics, and functional medicine programs.
Banking is the next logical step in that patient’s health protocol, and it is a step they will take with a physician they trust or with a service they find through a Google search. The question is whether that service is your practice or an unregulated clinic. Independent industry analysis projects double-digit compound annual growth through the end of the decade, and Save My Fat’s complete guide to banking covers the patient decision framework that drives demand in this segment.
The Technique Is Already in Your Skill Set
The banking harvest uses a small-bore cannula technique under local anesthesia to remove a small volume of adipose tissue from the abdomen or flank. Plastic surgeons, aesthetic physicians, and any physician comfortable with minor outpatient procedures already perform variations of this technique. The Save My Fat provider training covers the specific protocol, specimen handling, and chain-of-custody requirements. It does not require learning a new procedural category or acquiring new equipment beyond what is typically available in an existing outpatient practice. The foundational Zuk 2002 paper established the scientific basis for adipose as the preferred cell source, and Save My Fat’s overview of how banking works covers the procedural framework.
The Market Is Growing
More than four hundred active clinical trials are investigating ADSC and MSC therapies across orthopedic, autoimmune, neurological, and aesthetic applications. The FDA approved its first MSC-based biologic in December 2024, which is listed in the FDA approved cellular and gene therapy products database. Independent market projections show continued double-digit growth through the end of the decade. The physicians who establish their practices as trusted banking providers in 2026 are building patient relationships and institutional credibility in a market that will be significantly larger in five years than it is today.
The Compliance Framework: What You Need to Know
Section 361 HCT/P, the Regulatory Category
Banking under the Save My Fat program operates under FDA Section 361 of the Public Health Service Act, governed by 21 CFR Part 1271. This is the same regulatory framework that governs cord blood banking, bone marrow registries, and other tissue preservation services.
Under this framework, the compliance structure is clear:
- No Investigational New Drug application is required for the banking service itself.
- No FDA approval of the banking procedure is required, because banking is tissue preservation rather than an investigational therapeutic product.
- The processing laboratory, L2 Bio, must be registered with the FDA as an HCT/P establishment and operate under the applicable cGTP requirements.
- The tissue must be processed for autologous use only, meaning the patient’s own cells for their own future use.
- No treatment claims may be made about the banking service by the program, the partner providers, or the patient-facing materials.
Save My Fat’s overviews of FDA regulations for adipose tissue and 21 CFR Part 1271 cover the regulatory structure in more depth, and both resources are appropriate references for a practice administrator or legal counsel evaluating the program.
What You Are Not Doing
Banking is not a stem cell treatment. Partner providers are not injecting cells into patients, not making therapeutic claims about banked cells, and not operating outside the Section 361 HCT/P framework. The distinction between compliant banking and unregulated stem cell treatment is the compliance foundation the entire program is built on, and it is the protection that keeps both providers and patients on the right side of FDA enforcement. Save My Fat’s comparison of banking vs. stem cell treatment clinics covers the distinction in more depth for any physician who wants to review the boundary explicitly before committing to the program.
Informed Consent
Partners use the Save My Fat informed consent documentation, which covers the harvest procedure, what banking provides and does not provide, and the chain-of-custody process from harvest through long-term storage. Informed consent is both a regulatory requirement under 21 CFR Part 1271 and a patient protection standard that any responsible provider will recognize as foundational. Save My Fat’s overview of informed consent in regenerative medicine covers the framework that the partner consent process operates within.
The Workflow in Practice
What a Banking Appointment Looks Like
A typical banking appointment at a partner provider’s practice follows a clear sequence.
- Patient consultation. Review health history, confirm harvest candidacy, review and sign informed consent. Thirty to forty-five minutes, typically scheduled as a separate consultation appointment or combined with a same-day harvest for established patients.
- Harvest procedure. Local anesthesia, small-bore cannula harvest from the abdomen or flank, light dressing applied at the entry point. Approximately thirty minutes of active procedure time.
- Specimen packaging. Package the harvested tissue using the Save My Fat chain-of-custody protocol for shipping to L2 Bio. Includes documentation capture at the packaging step.
- Shipping. The specimen ships to L2 Bio per the protocol requirements, with chain-of-custody documentation accompanying the package through the shipping pipeline.
Total provider time per banking patient is approximately sixty to ninety minutes including consultation and procedure. This is a straightforward addition to an existing outpatient appointment schedule for most practice structures.
Same-Visit Banking
For plastic surgeons and aesthetic physicians performing fat grafting, liposuction, or body contouring procedures, banking can be offered as a same-visit service. The harvest for banking uses the same technique as the primary procedure, and a portion of the harvested tissue is allocated for banking. This is the highest-efficiency workflow for providers already harvesting fat, because the incremental patient experience is minimal and the incremental clinical workflow is a specimen allocation rather than a separate procedure. The foundational Zuk 2002 paper established the scientific basis for adipose as the preferred cell source across these procedural contexts, and Save My Fat’s overview of how banking works covers the chain-of-custody considerations for same-visit allocation.
Patient Communication Materials
Save My Fat provides patient education materials that support the provider conversation, including the content from this May 2026 blog series and the patient-facing reference pages on the Save My Fat website. Partners do not need to build their patient education infrastructure from scratch, and the materials are available for sharing with patients before and after consultation. This reduces the education burden on the provider and ensures that patients arrive at the consultation with a consistent baseline of understanding about what banking is and what it is not.
The Provider Types That Are the Strongest Fit
Five physician specialties are the strongest fit for the Save My Fat partner program, based on the overlap between the specialty’s patient population and the banking candidate profile.
- Plastic surgeons already harvest fat for grafting, have existing patient trust for elective procedures, and serve a cash-pay-comfortable patient base that overlaps almost entirely with the banking candidate profile.
- Aesthetic physicians and dermatologists have the same patient demographics and cash-pay orientation, combined with minor procedure experience that translates directly to the banking harvest technique.
- Functional and concierge medicine physicians have longevity-oriented patient panels, are already recommending proactive health investments, and operate relationship-based practices where banking fits the existing patient conversation naturally.
- Orthopedic surgeons see patients whose conditions are directly in the ADSC pipeline’s most mature application category, and the orthopedic ADSC evidence base as covered in the published MSC biology literature makes banking a clinically coherent extension of the orthopedic practice.
- Rheumatologists and internists with autoimmune patient panels see patients who are among the most motivated banking candidates and the most in need of accurate information about the legitimate pipeline rather than unregulated clinic alternatives.
Save My Fat’s provider program page covers the partner framework across these specialties and the onboarding pathway that applies to each.
What Joining Involves
Training
Partner providers complete the Save My Fat provider training, which covers the harvest protocol and technique, specimen handling and chain-of-custody requirements, informed consent documentation and patient communication, and the regulatory compliance framework under 21 CFR Part 1271. Training is designed to be completed without significant disruption to an existing practice schedule, and the training content assumes the physician’s existing procedural competence rather than teaching outpatient procedure fundamentals from scratch.
Ongoing Requirements
Partner providers adhere to the Save My Fat protocol for every banking procedure, including chain-of-custody documentation and specimen shipping to L2 Bio. Compliance with 21 CFR Part 1271 requirements at the laboratory end is maintained through the L2 Bio partnership, and the provider-side responsibilities focus on harvest technique, specimen integrity, and accurate documentation at the point of care.
Patient Referrals
Save My Fat lists partner providers in its provider directory, which is accessible to patients searching for banking locations. As the Save My Fat patient base grows, driven in part by the content marketing that this blog series is part of, the provider directory becomes an increasingly active referral source for partner practices. This is a practical answer to the “how do patients find me” question that most new service lines face when practices add them, and the referral mechanism is built into the program structure rather than left to the partner practice to solve independently. Save My Fat’s provider program overview covers the directory framework and how partner practices appear in patient-facing search and referral flows.
Frequently Asked Questions from Physicians
Do I need an Investigational New Drug application to offer banking?
No. Banking under the Section 361 HCT/P framework at 21 CFR Part 1271 does not require an IND. The regulatory category is tissue preservation, not an investigational new drug or biological product. The exclusion is structural and applies to all compliant banking services that meet the Section 361 criteria.
What are my liability considerations as a partner provider?
This is a question for your malpractice carrier and legal counsel, who will review the specific scope of practice and the informed consent framework. Save My Fat can provide the program documentation your legal team needs to evaluate the arrangement, and the compliant regulatory framework at 21 CFR Part 1271 is the starting point for that review. Specific liability analysis depends on state law and your practice’s existing coverage, so the answer varies and is not something the program can answer on your behalf.
What happens if a patient wants to use their banked cells for a treatment I am not familiar with?
Vial release for clinical use is arranged through Save My Fat and L2 Bio, and requires physician involvement and eligibility confirmation at the receiving facility. The partner provider’s role is the harvest and the initial patient relationship, not the future clinical application. A patient accessing their cells for a trial or expanded access is working with the receiving facility’s clinical team for the therapeutic application, and the partner provider is not expected to manage a clinical specialty outside their practice scope.
Can I offer banking without being a plastic surgeon?
Yes. The harvest technique is within the scope of practice for any physician trained and comfortable with minor outpatient procedures under local anesthesia. The specific training requirements and scope of practice considerations for your specialty and state should be reviewed before joining, and state-specific considerations apply in Florida, Utah, and Nevada, which have stem cell-specific statutes that affect how consent and practice are structured.
How do I start the conversation with my practice administrator?
The provider overview at Save My Fat’s provider program page is the starting point for practice-level evaluation. It covers the program structure, training requirements, and partnership terms at the level of detail needed for an administrative review. A practice administrator typically needs the compliance framework, the workflow description, the cost and revenue structure, and the liability considerations as the four primary evaluation inputs, and the program documentation covers each of the four.
Key Takeaways
The Save My Fat provider program adds a Section 361 HCT/P-compliant banking service to your practice under a regulatory framework that requires no IND application and permits no treatment claims. The compliance framework is established, auditable, and consistent with the broader HCT/P tissue preservation category that governs services like cord blood banking.
The harvest technique is within the existing skill set of plastic surgeons, aesthetic physicians, and any physician comfortable with minor outpatient procedures under local anesthesia. The program training covers the specific Save My Fat protocol and chain-of-custody requirements rather than teaching procedural fundamentals from the ground up.
The banking patient is your existing patient demographic: health-forward, cash-pay, longevity-oriented, and already investing in proactive health services. Banking is a service-line extension rather than a patient-acquisition exercise, which is the economic feature that makes it one of the more operationally efficient additions available to a practice evaluating new services.
Five strongest-fit specialties are plastic surgery, aesthetic medicine, functional and concierge medicine, orthopedic surgery, and rheumatology or internal medicine with autoimmune patient panels. The program serves practices across these specialties with specialty-appropriate onboarding and workflow integration.
The ADSC market is growing across multiple dimensions. More than four hundred active trials in the clinical pipeline. The December 2024 FDA approval of the first MSC-based therapy. Independent market projections of double-digit CAGR through the end of the decade. Providers who establish themselves as banking partners now are building credibility and patient relationships in a market that will be significantly larger in five years.
Joining involves provider training, protocol adherence, inclusion in the Save My Fat provider directory, and the ongoing relationship with L2 Bio for specimen processing and storage. The commitment is modest relative to the patient relationship durability banking tends to produce, because a patient who banks with a partner provider typically returns to that provider for any future vial access conversations and for related health decisions over the banking term.
Ready to Learn More?
Before moving forward: the Save My Fat partner provider program operates under the Section 361 HCT/P framework at 21 CFR Part 1271 and does not involve the performance of stem cell treatments, therapeutic injections, or any procedure requiring an Investigational New Drug application. Partner providers perform the harvest and participate in the compliant chain-of-custody that governs the banking service. No ADSC-based therapy for any specific condition is available through the Save My Fat program as a medical treatment. Physicians considering partnership should independently verify applicable state licensing and informed-consent requirements, particularly in Florida, Utah, and Nevada, which have stem cell-specific statutes.
To review the provider program structure and partnership terms, visit the provider program overview. To begin the application and onboarding process, visit the partner sign-up page.
Save My Fat provides adipose tissue banking services in partnership with L2 Bio for laboratory operations. Save My Fat does not provide medical treatments, clinical trial enrollment, or Expanded Access services.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about neurologic treatment or research participation.
